These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8569990)

  • 1. The beginning of repeated hemodialysis treatment enhances some platelet functions in uremic patients.
    Krawczyk W; Dmoszýnska A; Marczewski K
    Nephron; 1995; 71(3):361-2. PubMed ID: 8569990
    [No Abstract]   [Full Text] [Related]  

  • 2. Skin bleeding time for the evaluation of uremic platelet dysfunction and effect of dialysis.
    Soyoral YU; Demir C; Begenik H; Esen R; Kucukoglu ME; Aldemir MN; Demirkiran D; Erkoc R
    Clin Appl Thromb Hemost; 2012; 18(2):185-8. PubMed ID: 22327827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Modification of uremic thrombocytopathy by hemodialysis].
    Frick U; Frick G; Vitu J; Wiedenhöft I
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(2):309-13. PubMed ID: 6194064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal platelet cytoskeletal assembly in hemodialyzed patients results in deficient tyrosine phosphorylation signaling.
    Díaz-Ricart M; Estebanell E; Cases A; Calls J; López-Pedret J; Carretero M; Castillo R; Ordinas A; Escolar G
    Kidney Int; 2000 May; 57(5):1905-14. PubMed ID: 10792609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelets and platelet function in patients with chronic uremia on maintenance hemodialysis.
    Jørgensen KA; Ingeberg S
    Nephron; 1979; 23(5):233-6. PubMed ID: 481658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intradialytic and postdialytic platelet activation, increased platelet phosphatidylserine exposure and ultrastructural changes in platelets in children with chronic uremia.
    Elshamaa MF; Elghoroury EA; Helmy A
    Blood Coagul Fibrinolysis; 2009 Jun; 20(4):230-9. PubMed ID: 19521197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uremic plasma after infusion of desmopressin (DDAVP) improves the interaction of normal platelets with vessel subendothelium.
    Escolar G; Cases A; Monteagudo J; Garrido M; Lopez J; Ordinas A; Revert L; Castillo R
    J Lab Clin Med; 1989 Jul; 114(1):36-42. PubMed ID: 2738447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of platelet abnormalities in uremia with and without Glanzmann's thrombasthenia.
    Nomura S; Hamamoto K; Kawakatsu T; Kido H; Yamaguchi K; Fukuroi T; Suzuki M; Yanabu M; Shouzu A; Nishikawa M
    Nephron; 1994; 68(4):442-8. PubMed ID: 7870229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced platelet apoptosis in chronic uremic patients.
    Li M; Wang Z; Ma T; Lu G; Yan R; Zhao L; Deng K; Dai K
    Ren Fail; 2014 Jul; 36(6):847-53. PubMed ID: 24655051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Change of platelet function after the beginning of repeated hemodialysis treatment in patients with uremia].
    Krawczyk W; Dmoszyńska A; Marczewski K; Rózyc P
    Pol Arch Med Wewn; 1994 Dec; 92(6):483-8. PubMed ID: 7716051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement of bleeding time, platelet aggregation and platelet count during CAPD treatment.
    Arends JP; Krediet RT; Boeschoten EW; van der Lelie J; Veenhof CH; von dem Borne AE
    Proc Eur Dial Transplant Assoc; 1981; 18():280-5. PubMed ID: 7329972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of uremia and hemodialysis on platelet apoptosis.
    Sobol AB; Kaminska M; Walczynska M; Walkowiak B
    Clin Appl Thromb Hemost; 2013 Jun; 19(3):320-3. PubMed ID: 22387580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma phospholipids and platelet function in uremic patients.
    Vecino A; Teruel JL; Navarro JL; Cesar JM
    Am J Nephrol; 1996; 16(5):409-11. PubMed ID: 8886178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of uremia on platelet contractile force, clot elastic modulus and bleeding time in hemodialysis patients.
    Brophy DF; Martin EJ; Carr SL; Kirschbaum B; Carr ME
    Thromb Res; 2007; 119(6):723-9. PubMed ID: 16793120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased platelet sensitivity to prostacyclin (epoprostenol) during hemodialysis.
    Kristensen SD; Knudsen F; Nielsen AH; Ring T
    Clin Nephrol; 1984 Apr; 21(4):230-4. PubMed ID: 6375926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of erythropoietin on platelet function in uraemic children on haemodialysis.
    Turi S; Soos J; Torday C; Bereczki C; Havass Z
    Pediatr Nephrol; 1994 Dec; 8(6):727-32. PubMed ID: 7696114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant human erythropoietin treatment improves platelet function in uremic patients.
    Cases A; Escolar G; Reverter JC; Ordinas A; Lopez-Pedret J; Revert L; Castillo R
    Kidney Int; 1992 Sep; 42(3):668-72. PubMed ID: 1405344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced nitric oxide synthesis in uremia: implications for platelet dysfunction and dialysis hypotension.
    Noris M; Benigni A; Boccardo P; Aiello S; Gaspari F; Todeschini M; Figliuzzi M; Remuzzi G
    Kidney Int; 1993 Aug; 44(2):445-50. PubMed ID: 8377388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation and partial characterization of platelet aggregation inhibitors in the blood of dialyzed patients.
    Mabuchi H; Nakahashi H
    Nephron; 1983; 35(2):112-5. PubMed ID: 6621755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Desmopressin improves platelet function in uremic patients taking antiplatelet agents who require emergent invasive procedures.
    Kim JH; Baek CH; Min JY; Kim JS; Kim SB; Kim H
    Ann Hematol; 2015 Sep; 94(9):1457-61. PubMed ID: 25933676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.